Umasankar De Selected Research

Umasankar De Research Topics

Disease

10	Neoplasms (Cancer) 03/2024 - 06/2013
6	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2014
3	Prostatic Neoplasms (Prostate Cancer) 09/2015 - 05/2011
1	Parotitis (Parotiditis) 04/2024
1	Multiple Myeloma 02/2024
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023
1	Carcinoma (Carcinomatosis) 10/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Ovarian Epithelial Carcinoma 01/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2018
1	Endometrial Neoplasms (Endometrial Cancer) 09/2018
1	Wounds and Injuries (Trauma) 04/2018
1	Adenocarcinoma 01/2017

Drug/Important Bio-Agent (IBA)

3	Histone Deacetylase InhibitorsIBA 09/2018 - 06/2013
2	RNA (Ribonucleic Acid)IBA 04/2024 - 10/2021
2	Proteolysis Targeting ChimeraIBA 03/2024 - 01/2021
2	snake venom protein C activatorIBA 03/2024 - 01/2021
2	Histones (Histone)IBA 02/2024 - 06/2013
2	SirtuinsIBA 09/2018 - 01/2016
2	N1- hydroxy- N8- (4- (phenylamino)phenyl)octanediamideIBA 09/2015 - 06/2013
2	Antineoplastic Agents (Antineoplastics)IBA 09/2015 - 06/2013
2	Histone Deacetylases (Histone Deacetylase)IBA 09/2015 - 06/2013
1	DT2216IBA 01/2023
1	Apoptosis Regulatory ProteinsIBA 01/2023
1	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 01/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2021
1	plumbaginIBA 01/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 10/2018
1	TensinsIBA 10/2018
1	Thyroid Hormone-Binding ProteinsIBA 10/2018
1	Everolimus FDA Link 10/2018
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 10/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2018
1	Hormones (Hormone)IBA 09/2018
1	AntioxidantsIBA 04/2018
1	Pyridoxine (Pyridoxin)FDA LinkGeneric 04/2018
1	AndrogensIBA 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 10/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2014
1	anthraceneIBA 01/2014
1	Androgen Receptors (Androgen Receptor)IBA 06/2013
1	Vorinostat FDA Link 06/2013
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 05/2011
1	MHY336IBA 05/2011
1	Topoisomerase II InhibitorsIBA 05/2011
1	FlavonoidsIBA 05/2011

Therapy/Procedure

3	Immunotherapy 03/2024 - 01/2021
3	Therapeutics 03/2024 - 10/2018
2	Drug Therapy (Chemotherapy) 09/2015 - 06/2013
1	Molecular Targeted Therapy 10/2018